enoxaparin, Lovenox (cont.)

Pharmacy Author:

Omudhome Ogbru, PharmD

Omudhome Ogbru, PharmD

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

View Full Profile

Medical and Pharmacy Editor:

Jay W. Marks, MD

Jay W. Marks, MD

Jay W. Marks, MD, is a board-certified internist and gastroenterologist. He graduated from Yale University School of Medicine and trained in internal medicine and gastroenterology at UCLA/Cedars-Sinai Medical Center in Los Angeles.

View Full Profile

PREGNANCY: Enoxaparin does not cross the placenta and shows no evidence of effects on the fetus. It often is used during pregnancy as an alternative to oral anticoagulants such as warfarin (Coumadin), which cannot be safely used during pregnancy.

NURSING MOTHERS: It is not known if enoxaparin is excreted in breast milk. Since most medicines are excreted in breast milk, it is recommended that women receiving enoxaparin should not breastfeed.

SIDE EFFECTS: The most common side effect associated with enoxaparin is bleeding. Fever, nausea, diarrhea, and fluid retention are common. Less commonly, enoxaparin can induce abnormal liver tests in the blood, suggesting mild damage to the liver, and a reduction in blood platelets and red blood cells. Mild local irritation, pain, hematoma, ecchymosis, and erythema may occur at the site of injection. Hypersensitivity reactions also may occur.

Reference: FDA Prescribing Information

Report Problems to the Food and Drug Administration You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088. Need help identifying pills and medications? Use the pill identifier tool on RxList.